The urokinase pathway of the plasminogen activation is involved in pro
teolytic degradation of various tissues, including dissolution of the
extracellular matrix and basement membranes during the process of canc
er cell invasion. Recent studies have demonstrated that components of
the plasminogen activation system have a prognostic impact in breast-,
lung-, colorectal, bladder and gastric cancer. A number of studies, r
eviewed here, have focused on the role of the plasminogen activation s
ystem in different lung cancer types. There seems to be an obvious dif
ference between the expression, localization and prognostic impact of
the components of the plasminogen activation system in different lung
cancer types. The differences seen could be helpful in understanding t
he biology of different lung cancer types, and components of the plasm
inogen activation system may have prognostic relevance and clinical im
plications in some lung cancer types, even though confirmatory studies
are needed.